Volume of breast milk.
Conditions
Interventions
Intervention 1: Intervention group: Mothers in the experimental group are given Silimarin tablets in the form of liver-coated tablets of 140 mg three times a day. Intervention 2: Control group: The pl
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: inclusion criteria for mothers: presence of the mother in the neonatal intensive care unit, having decided to breastfeed. inclusion criteria for infants: premature infants with a gestational age of more than 28 weeks, a calendar age of at least three days.
Exclusion criteria
Exclusion criteria: Exclusion criteria for mothers: mother's addiction, suffering from tuberculosis, AIDS, cancer, presence of breast abscess, presence of purulent secretions in breast milk or presence of blood in breast milk, mood disorders such as depression or psychosis after childbirth. Exclusion criteria for babies: having defects Clear genetic and congenital or disorders of the digestive system that prevent breastfeeding, such as gastroschisis, emphalocele, cerebral hemorrhage with degree 3 and 4, a baby undergoing surgery or mechanical ventilation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Volume of breast milk. Timepoint: Average milk expressed by mothers on the first, 7th and 14th days of the intervention. Method of measurement: The amount of expressed milk is measured with a 20 cc syringe and recorded with the time in the checklist during the two weeks of the intervention. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKhadijeh Dehghani
Yazd University of Medical Sciences
Outcome results
None listed